Clinical characteristics and outcomes in acute myocardial infarction patients aged ≥65 years in Western Romania

被引:5
作者
Caruntu, Florina [1 ,2 ]
Bordejevic, Diana Aurora [1 ,2 ]
Tomescu, Mirela Cleopatra [1 ,2 ]
Citu, Ioana Mihaela [1 ,2 ]
机构
[1] Timisoara Municipal Clin Emergency Hosp, Cardiol Clin, Timisoara 300024, Romania
[2] Victor Babes Univ Med & Pharm, Multidisciplinary Heart Res Ctr, Timisoara 300041, Romania
关键词
Acute myocardial infarction; PCI; Age >= 65 years; Prognosis; PERCUTANEOUS CORONARY INTERVENTION; ELDERLY-PATIENTS; EUROPEAN-ASSOCIATION; GUIDELINES; THERAPY; DISEASE; ESC; MANAGEMENT; SOCIETY; TRIALS;
D O I
10.31083/j.rcm2203098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Older age is known as a negative prognostic parameter in patients with acute myocardial infarction (AMI). In this study, we aimed to investigate age-related differences in treatment protocols, in-hospital and 1-year mortality. This retrospective observational single-center study enrolled consecutive AMI patients with an urgent percutaneous coronary intervention (PCI) as the main method of myocardial revascularization. The patients divided were divided by age into group I (>= 65 years) and group II (<65 years). The primary endpoint was in-hospital mortality, the secondary endpoints were 1-year mortality and rehospitalization rates. Of the 522 admitted with AMI, 476 were enrolled in the study. The mean age was 67 +/- 13 years; 62% were men. Group I patients had a significantly lower rate of performed PCI (65% vs. 79%, P< 0.001). 53 patients (12.3%) died during hospitalization, and this proportion was notably higher in the older population (20% vs. 6%, P < 0.0001). The cardiac causes of death were more frequent in group I patients (12% vs. 5.6%, P = 0.016). The multivariate logistic regression selected two variables as independent predictors for the risk of in-hospital death: age >= 65 years (P = 0.0170), and Killip class at admission ( P < 0.0001). The 1-year mortality was 3.3%, slightly higher in group I patients (4.8% vs. 1.5%, P = 0.05). In conclusion, patients aged >= 65 years have three times higher in-hospital mortality, but similar 1-year mortality and readmission rates when compared with the younger patients. It is obvious that there is a large potential for improvement of the AMI care in this age group of patients.
引用
收藏
页码:911 / 918
页数:8
相关论文
共 27 条
  • [1] 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
    Aboyans, Victor
    Ricco, Jean-Baptiste
    Bartelink, Marie-Louise E. L.
    Bjoerck, Martin
    Brodmann, Marianne
    Cohnert, Tina
    Collet, Jean-Philippe
    Czerny, Martin
    De Carlo, Marco
    Debus, Sebastian
    Espinola-Klein, Christine
    Kahan, Thomas
    Kownator, Serge
    Mazzolai, Lucia
    Naylor, A. Ross
    Roffi, Marco
    Roether, Joachim
    Sprynger, Muriel
    Tendera, Michal
    Tepe, Gunnar
    Venermo, Maarit
    Vlachopoulos, Charalambos
    Desormais, Ileana
    [J]. KARDIOLOGIA POLSKA, 2017, 75 (11) : 1065 - 1160
  • [2] [Anonymous], 2011, DEF OLD ELD PERS
  • [3] Baumgartner H, 2022, EUR HEART J, V41, P111
  • [4] Baumgartner H, 2018, EUR HEART J, V39, P1980, DOI [10.1093/eurheartj/ehx636, 10.1093/eurheartj/ehx391]
  • [5] HEMORRHAGIC EVENTS DURING THERAPY WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, HEPARIN, AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI), PHASE-II TRIAL
    BOVILL, EG
    TERRIN, ML
    STUMP, DC
    BERKE, AD
    FREDERICK, M
    COLLEN, D
    FEIT, F
    GORE, JM
    HILLIS, LD
    LAMBREW, CT
    LEIBOFF, R
    MANN, KG
    MARKIS, JE
    PRATT, CM
    SHARKEY, SW
    SOPKO, G
    TRACY, RP
    CHESEBRO, JH
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (04) : 256 - 265
  • [6] Collet JP, 2020, Eur Heart J, P1, DOI [10.1093/eurheartj/ehaa575.2, DOI 10.1093/EURHEARTJ/EHAA575.2]
  • [7] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco
    Grant, Peter J.
    Aboyans, Victor
    Bailey, Clifford J.
    Ceriello, Antonio
    Delgado, Victoria
    Federici, Massimo
    Filippatos, Gerasimos
    Grobbee, Diederick E.
    Hansen, Tina Birgitte
    Huikuri, Heikki, V
    Johansson, Isabelle
    Juni, Peter
    Lettino, Maddalena
    Marx, Nikolaus
    Mellbin, Linda G.
    Ostgren, Carl J.
    Rocca, Bianca
    Roffi, Marco
    Sattar, Naveed
    Seferovic, Petar M.
    Sousa-Uva, Miguel
    Valensi, Paul
    Wheeler, David C.
    Piepoli, Massimo Francesco
    Birkeland, Kare, I
    Adamopoulos, Stamatis
    Ajjan, Ramzi
    Avogaro, Angelo
    Baigent, Colin
    Brodmann, Marianne
    Bueno, Hector
    Ceconi, Claudio
    Chioncel, Ovidiu
    Coats, Andrew
    Collet, Jean-Philippe
    Collins, Peter
    Cosyns, Bernard
    Di Mario, Carlo
    Fisher, Miles
    Fitzsimons, Donna
    Halvorsen, Sigrun
    Hansen, Dominique
    Hoes, Arno
    Holt, Richard I. G.
    Home, Philip
    Katus, Hugo A.
    Khunti, Kamlesh
    Komajda, Michel
    Lambrinou, Ekaterini
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (02) : 255 - 323
  • [8] Clinical end points in coronary stent trials - A case for standardized definitions
    Cutlip, Donald E.
    Windecker, Stephan
    Mehran, Roxana
    Boam, Ashley
    Cohen, David J.
    van Es, Gerrit-Anne
    Steg, P. Gabriel
    Morel, Marie-angele
    Mauri, Laura
    Vranckx, Pascal
    McFadden, Eugene
    Lansky, Alexandra
    Hamon, Martial
    Krucoff, Mitchell W.
    Serruys, Patrick W.
    [J]. CIRCULATION, 2007, 115 (17) : 2344 - 2351
  • [9] Danchin N, 2010, ANN CARDIOL ANGEIOL, V59, pS85
  • [10] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword
    Eknoyan, G
    Levin, NW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : S14 - S266